Written by Marcus W.
Published April 9, 2026

Head-to-head clinical trials show that structured aerobic exercise produces antidepressant effects comparable to first-line medications in adults with mild-to-moderate *major depressive disorder* (MDD) — and combining both may outperform either alone.
Major depressive disorder (MDD) is a clinical diagnosis defined by at least two weeks of persistent low mood, loss of interest, and associated symptoms — sleep disruption, fatigue, difficulty concentrating — that impair daily functioning. It is distinct from situational sadness. According to the National Institute of Mental Health, approximately 6% of U.S. adults experience at least one major depressive episode per year, and men are significantly less likely than women to seek treatment.
Selective serotonin reuptake inhibitors (SSRIs) — the most commonly prescribed antidepressant class — block the reabsorption of serotonin in the synaptic cleft, increasing its availability between neurons. Serotonin-norepinephrine reuptake inhibitors (SNRIs) act on both serotonin and norepinephrine pathways. Both classes typically require four to eight weeks for full clinical effect. They are FDA-approved for MDD and carry a well-characterized side-effect profile including sexual dysfunction, weight changes, and, particularly in the first weeks of treatment, increased suicidal ideation in younger patients — a risk warranting close provider monitoring.
Exercise is not simply "feeling better after a run." Aerobic activity triggers measurable neurobiological changes. It increases circulating brain-derived neurotrophic factor (BDNF) — a protein that supports neuron growth and synaptic plasticity in regions like the hippocampus that are structurally reduced in MDD. It also elevates endorphins, dopamine, and serotonin, and downregulates the hypothalamic-pituitary-adrenal (HPA) axis, the stress-response system that is chronically dysregulated in depression.
The landmark SMILE (Standard Medical Intervention and Long-term Exercise) trial, published in the *Archives of Internal Medicine*, randomized 156 adults with MDD to one of three arms: aerobic exercise alone (30 minutes, three times per week), sertraline (an SSRI) alone, or a combination of both. At 16 weeks, all three groups showed equivalent reductions in depression scores on the Hamilton Rating Scale for Depression (HAM-D). Results may vary. A 10-month follow-up found that participants in the exercise-only group had significantly lower relapse rates than those in the medication-only group.

A comprehensive Cochrane systematic review analyzing 39 randomized controlled trials found that exercise produced a moderate-to-large antidepressant effect compared to control conditions, and that when compared directly to antidepressant medication, the difference was not statistically significant. The reviewers noted that trial quality varied and that blinding patients to exercise interventions is inherently difficult, which may introduce bias.
A 2023 meta-analysis published in the *British Medical Journal* — one of the most rigorous to date — analyzed 218 randomized controlled trials involving more than 14,000 participants. It found that walking, jogging, yoga, and strength training were all effective for reducing depressive symptoms, with higher-intensity exercise producing larger effects. Crucially, the authors concluded that exercise was comparable to psychotherapy and pharmacotherapy for mild-to-moderate MDD. Results may vary.
We don't yet know whether exercise alone is sufficient for severe MDD, psychotic depression, or MDD with active suicidality. The evidence base for those populations strongly favors pharmacological and inpatient intervention. We also don't yet have large, long-term trial data on men aged 45–70 as a discrete subgroup, though the existing data does not suggest this cohort responds differently.
Potentially appropriate candidates (per prescribing provider evaluation): - Men with mild-to-moderate MDD who are medically cleared for aerobic exercise - Those with a prior positive response to exercise - Men who are intolerant of SSRI/SNRI side effects (particularly sexual dysfunction, which is reported by up to 40% of patients on SSRIs, per *JAMA*) - Those seeking an adjunct to ongoing pharmacotherapy
Exercise alone is NOT appropriate as primary treatment for: - Severe MDD (PHQ-9 score ≥ 20) - MDD with active suicidal ideation — contact the 988 Suicide & Crisis Lifeline immediately or go to the nearest emergency department - Bipolar disorder (misdiagnosis is common; requires separate evaluation) - MDD with psychotic features - Patients with cardiovascular contraindications to vigorous exercise
Exercise: Clinical improvement in mood typically begins within two to four weeks of consistent aerobic activity (three to five sessions per week, 30–45 minutes per session at moderate intensity). Early side effects are musculoskeletal — soreness, fatigue — and resolve with conditioning. There is no discontinuation syndrome. Adherence is the primary clinical challenge.
SSRIs/SNRIs: Therapeutic effect generally requires four to eight weeks. Common early side effects include nausea, insomnia, and headache, most of which resolve within two weeks. Sexual dysfunction and weight gain may persist. Do not stop an antidepressant without provider guidance — abrupt discontinuation can cause discontinuation syndrome, characterized by dizziness, flu-like symptoms, and mood instability.
If your mood worsens, you develop new or increased thoughts of self-harm, or you experience any concerning symptom on either treatment, contact your licensed provider through the patient portal immediately — not support staff.

May is Testicular Cancer Awareness Month. This is an appropriate moment to note that testicular cancer is the most common cancer in men aged 15–35, and that depression is a documented sequela of cancer diagnosis and treatment. If you are a survivor or currently in treatment, discuss both your mental health and routine testicular self-examination with your provider. The Movember Foundation offers evidence-based resources on men's cancer and mental health.
Good Guy Rx is a technology platform that connects you to independent licensed physicians and independent state-licensed pharmacies. If you are experiencing symptoms of depression and want a clinical evaluation — including a discussion of whether exercise, medication, or a combination is appropriate for your specific presentation — the prescribing provider determines the right approach after a thorough medical intake. Start with the men's mental health assessment to connect with a licensed provider.
Sources
This article is educational. A licensed provider determines whether you are a candidate after a medical intake.
References
Share this article

Complete your free online visit and see if GLP-1 treatment is right for you.
Get Started